Home / KNSA : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does KNSA make money? Does KNSA have pricing power? What's the Earnings Whisper? Will KNSA profit more as the business scales? What is KNSA's management track record? Is KNSA's current price justified?

Kiniksa Pharmaceuticals International, plc

$76.27 +$34.26 (+81.55%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$76.48

Day Range

$76.14$78.59

Year Range

$35.2$82.94

Market Cap

5.81B

AVG Volume

675.88K

Trailing/Forward PE

71.28/37.18

PEG ratio

1.51

Dividend Yield

Next Earnings Date

2026-10-27

Primary Exchange

NASDAQ

Revenue (USD)

KNSA Revenue (USD) by quarter
Period	Revenue (USD)
26 Q2	243.6M
26 Q1	214.27M
25 Q4	202.13M
25 Q3	180.85M
25 Q2	156.8M
25 Q1	137.78M
24 Q4	122.54M
24 Q3	112.21M
24 Q2	108.63M
24 Q1	79.86M

Net Income (USD)

KNSA Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	25.43M
26 Q1	22.59M
25 Q4	14.2M
25 Q3	18.43M
25 Q2	17.83M
25 Q1	8.54M
24 Q4	-8.89M
24 Q3	-12.69M
24 Q2	-3.91M
24 Q1	-17.7M

Operating Income (USD)

KNSA Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	27.19M
26 Q1	29.27M
25 Q4	19.77M
25 Q3	24.02M
25 Q2	20.16M
25 Q1	13.27M
24 Q4	-19.3M
24 Q3	-9.66M
24 Q2	-117K
24 Q1	-16.54M

EBITDA (USD)

KNSA EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q2	27.67M
26 Q1	33.15M
25 Q4	23.74M
25 Q3	27.54M
25 Q2	23.23M
25 Q1	15.91M
24 Q4	-16.58M
24 Q3	-6.8M
24 Q2	2.73M
24 Q1	-13.81M

Cash Flows (USD)

KNSA Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q2	46.8M
26 Q1	50.04M
25 Q4	53.26M
25 Q3	33.01M
25 Q2	27.93M
25 Q1	22.23M
24 Q4	18.58M
24 Q3	-2.24M
24 Q2	5.17M
24 Q1	3.9M

EPS (USD)

KNSA EPS (USD) by quarter
Period	EPS (USD)
26 Q2	0.3
26 Q1	0.27
25 Q4	0.18
25 Q3	0.23
25 Q2	0.23
25 Q1	0.11
24 Q4	-0.12
24 Q3	-0.18
24 Q2	-0.06
24 Q1	-0.25

Expenses (USD)

KNSA Expenses (USD) by quarter
Period	Expenses (USD)
26 Q2	105.43M
26 Q1	88.79M
25 Q4	92.04M
25 Q3	73.91M
25 Q2	65.78M
25 Q1	62.95M
24 Q4	75.86M
24 Q3	72.46M
24 Q2	66.29M
24 Q1	64.95M

Cash & Debt (USD)

KNSA Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q2	525.93M
26 Q1	468.09M
25 Q4	414.07M
25 Q3	352.1M
25 Q2	307.78M
25 Q1	268.34M
24 Q4	243.63M
24 Q3	223.78M
24 Q2	218.76M
24 Q1	213.55M

Debt ratios

KNSA Debt ratios by quarter
Period	Debt ratios
26 Q2	-4.61
26 Q1	-4.26
25 Q4	-4.47
25 Q3	-6.83
25 Q2	-18.9
25 Q1	54.55
24 Q4	6.78
24 Q3	14.03
24 Q2	13.05
24 Q1	10.71

Margins

KNSA Margins by quarter
Period	Margins
26 Q2	54.17%
26 Q1	55.02%
25 Q4	54.93%
25 Q3	53.78%
25 Q2	54.7%
25 Q1	55.25%
24 Q4	46%
24 Q3	55.96%
24 Q2	60.92%
24 Q1	60.51%

Return on Capital

KNSA Return on Capital by quarter
Period	Return on Capital
26 Q2	3.89%
26 Q1	3.73%
25 Q4	2.5%
25 Q3	3.44%
25 Q2	3.6%
25 Q1	1.87%
24 Q4	-2.03%
24 Q3	-2.9%
24 Q2	-0.9%
24 Q1	-4.1%

Shares Outstanding

KNSA Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	77.58M
26 Q1	76.52M
25 Q4	74.2M
25 Q3	73.61M
25 Q2	73.44M
25 Q1	72.65M
24 Q4	72.32M
24 Q3	71.73M
24 Q2	71M
24 Q1	70.63M

Book Value Per Share (USD)

KNSA Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q2	8.43
26 Q1	7.92
25 Q4	7.65
25 Q3	7.27
25 Q2	6.74
25 Q1	6.3
24 Q4	6.06
24 Q3	6.09
24 Q2	6.13
24 Q1	6.11

Total Assets (USD)

KNSA Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q2	896.11M
26 Q1	825.28M
25 Q4	763.63M
25 Q3	712.33M
25 Q2	661.15M
25 Q1	599.33M
24 Q4	580.55M
24 Q3	555.3M
24 Q2	542.43M
24 Q1	519.67M

Employee Count

KNSA Employee Count by quarter
Period	Employee Count
2025	366
2024	315
2023	297
2022	220
2021	215
2020	168
2019	137
2018	111

PE Ratio

KNSA PE Ratio by quarter
Period	PE Ratio
Sep 26	73.36
Sep 26	74.93
Aug 26	75.1
Aug 26	76.01
Aug 26	73.82
Aug 26	73.16
Jul 26	71.5
Jul 26	65.81
Jul 26	66.98
Jul 26	66.44
Jul 26	67.58
Jun 26	62
Jun 26	57.72
Jun 26	54.35
Jun 26	50.71
May 26	50.67
May 26	55.76
May 26	59.19
May 26	61.37
May 26	57.89
Apr 26	53.81
Apr 26	56.46
Apr 26	59.2
Apr 26	61.39
Mar 26	57.53
Mar 26	57.95
Mar 26	57.57
Mar 26	58.05
Feb 26	55.95
Feb 26	97.89
Feb 26	92.98
Feb 26	88.3
Jan 26	90
Jan 26	86.48
Jan 26	80.76
Jan 26	87.44
Jan 26	86.09
Dec 25	86.07
Dec 25	88.51
Dec 25	85.23
Dec 25	85.39
Nov 25	87.13
Nov 25	85.21
Nov 25	82.63
Nov 25	78.63
Oct 25	75.84
Oct 25	596.86
Oct 25	592.42
Oct 25	580.92
Oct 25	590.12
Sep 25	559.45
Sep 25	543.05
Sep 25	568.81
Sep 25	547.5
Aug 25	513.46
Aug 25	517.45
Aug 25	511.77
Aug 25	492.92
Aug 25	490.31
Jul 24	173.36
Jul 24	173.19
Jul 24	158.09
Jun 24	152.45
Jun 24	151.96
Jun 24	153.27
Jun 24	155.64
May 24	155.23
May 24	155.56
May 24	161.44
May 24	159.48
May 24	163.97
Apr 24	146
Apr 24	84.49
Apr 24	86.39
Apr 24	89.44
Mar 24	98.58
Mar 24	99.78
Mar 24	99.88
Mar 24	103.98
Mar 24	108.63
Oct 23	4.61
Oct 23	4.71
Oct 23	4.93
Oct 23	4.98
Sep 23	5.25
Sep 23	5.03
Sep 23	5.18
Sep 23	5.22
Sep 23	5.37
Aug 23	5.28
Aug 23	5.09
Aug 23	5.17
Aug 23	5.53
Jul 23	6.73
Jul 23	5.54
Jul 23	5.16
Jul 23	4.84
Jun 23	5
Jun 23	5.49
Jun 23	5.53

Free Cash Flow Yield

KNSA Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	3.09%
Sep 26	3.03%
Aug 26	3.02%
Aug 26	2.99%
Aug 26	3.08%
Aug 26	3.1%
Jul 26	3.17%
Jul 26	3.42%
Jul 26	3.36%
Jul 26	3.38%
Jul 26	3.33%
Jun 26	3.63%
Jun 26	3.89%
Jun 26	4.14%
Jun 26	4.43%
May 26	4.44%
May 26	4.03%
May 26	3.8%
May 26	3.66%
May 26	3.88%
Apr 26	4.3%
Apr 26	4.09%
Apr 26	3.91%
Apr 26	3.77%
Mar 26	4.02%
Mar 26	3.99%
Mar 26	4.02%
Mar 26	3.98%
Feb 26	4.13%
Feb 26	2.89%
Feb 26	3.05%
Feb 26	3.21%
Jan 26	3.15%
Jan 26	3.28%
Jan 26	3.51%
Jan 26	3.24%
Jan 26	3.29%
Dec 25	3.29%
Dec 25	3.2%
Dec 25	3.32%
Dec 25	3.32%
Nov 25	3.25%
Nov 25	3.32%
Nov 25	3.43%
Nov 25	3.6%
Oct 25	3.73%
Oct 25	2.33%
Oct 25	2.34%
Oct 25	2.39%
Oct 25	2.35%
Sep 25	2.48%
Sep 25	2.56%
Sep 25	2.44%
Sep 25	2.54%
Aug 25	2.7%
Aug 25	2.68%
Aug 25	2.71%
Aug 25	2.82%
Aug 25	2.83%
Jul 25	2.29%
Jul 25	2.07%
Jul 25	2.14%
Jul 25	2.16%
Jun 25	2.15%
Jun 25	2.12%
Jun 25	2.13%
Jun 25	1.99%
May 25	2.2%
May 25	2.24%
May 25	2.29%
May 25	2.31%
May 25	2.18%
Apr 25	1.64%
Apr 25	1.74%
Apr 25	1.82%
Apr 25	1.73%
Mar 25	1.52%
Mar 25	1.5%
Mar 25	1.55%
Mar 25	1.63%
Feb 25	1.73%
Feb 25	0.77%
Feb 25	0.78%
Feb 25	0.79%
Jan 25	0.79%
Jan 25	0.77%
Jan 25	0.84%
Jan 25	0.78%
Jan 25	0.76%
Dec 24	0.77%
Dec 24	0.75%
Dec 24	0.77%
Dec 24	0.72%
Nov 24	0.7%
Nov 24	0.73%
Nov 24	0.73%
Nov 24	0.68%
Nov 24	0.69%
Oct 24	1.56%
Oct 24	1.63%

Price to Sales

KNSA Price to Sales by quarter
Period	Price to Sales
Sep 26	7.04
Sep 26	7.19
Aug 26	7.2
Aug 26	7.29
Aug 26	7.08
Aug 26	7.02
Jul 26	6.86
Jul 26	6.38
Jul 26	6.49
Jul 26	6.44
Jul 26	6.55
Jun 26	6.01
Jun 26	5.59
Jun 26	5.27
Jun 26	4.91
May 26	4.91
May 26	5.4
May 26	5.73
May 26	5.95
May 26	5.61
Apr 26	4.69
Apr 26	4.92
Apr 26	5.16
Apr 26	5.35
Mar 26	5.01
Mar 26	5.05
Mar 26	5.01
Mar 26	5.06
Feb 26	4.87
Feb 26	5.88
Feb 26	5.58
Feb 26	5.3
Jan 26	5.41
Jan 26	5.19
Jan 26	4.85
Jan 26	5.25
Jan 26	5.17
Dec 25	5.17
Dec 25	5.32
Dec 25	5.12
Dec 25	5.13
Nov 25	5.23
Nov 25	5.12
Nov 25	4.96
Nov 25	4.72
Oct 25	4.56
Oct 25	5.4
Oct 25	5.36
Oct 25	5.26
Oct 25	5.34
Sep 25	5.06
Sep 25	4.91
Sep 25	5.15
Sep 25	4.95
Aug 25	4.65
Aug 25	4.68
Aug 25	4.63
Aug 25	4.46
Aug 25	4.44
Jul 25	3.98
Jul 25	4.38
Jul 25	4.24
Jul 25	4.21
Jun 25	4.23
Jun 25	4.29
Jun 25	4.27
Jun 25	4.56
May 25	4.13
May 25	4.06
May 25	3.96
May 25	3.93
May 25	4.17
Apr 25	3.65
Apr 25	3.45
Apr 25	3.3
Apr 25	3.48
Mar 25	3.95
Mar 25	3.99
Mar 25	3.86
Mar 25	3.68
Feb 25	3.47
Feb 25	3.74
Feb 25	3.69
Feb 25	3.64
Jan 25	3.66
Jan 25	3.74
Jan 25	3.46
Jan 25	3.72
Jan 25	3.79
Dec 24	3.74
Dec 24	3.85
Dec 24	3.77
Dec 24	4.02
Nov 24	4.12
Nov 24	3.97
Nov 24	3.98
Nov 24	4.27
Nov 24	4.2
Oct 24	5.75
Oct 24	5.5

EV/EBITDA

KNSA EV/EBITDA by quarter
Period	EV/EBITDA
Sep 26	48.17
Sep 26	49.31
Aug 26	49.43
Aug 26	50.08
Aug 26	48.51
Aug 26	48.03
Jul 26	46.84
Jul 26	40.4
Jul 26	41.19
Jul 26	40.82
Jul 26	41.6
Jun 26	37.81
Jun 26	34.9
Jun 26	32.62
Jun 26	30.15
May 26	30.12
May 26	33.57
May 26	35.9
May 26	37.38
May 26	35.02
Apr 26	30.64
Apr 26	32.37
Apr 26	34.16
Apr 26	35.59
Mar 26	33.07
Mar 26	33.34
Mar 26	33.09
Mar 26	33.4
Feb 26	32.03
Feb 26	63.34
Feb 26	59.81
Feb 26	56.46
Jan 26	57.68
Jan 26	55.16
Jan 26	51.06
Jan 26	55.85
Jan 26	54.88
Dec 25	54.86
Dec 25	56.61
Dec 25	54.26
Dec 25	54.38
Nov 25	55.63
Nov 25	54.25
Nov 25	52.4
Nov 25	49.53
Oct 25	47.53
Oct 25	162.46
Oct 25	161.11
Oct 25	157.61
Oct 25	160.41
Sep 25	151.09
Sep 25	146.1
Sep 25	153.93
Sep 25	147.46
Aug 25	137.11
Aug 25	138.32
Aug 25	136.6
Aug 25	130.87
Aug 25	130.08
Oct 23	18.96
Oct 23	19.43
Oct 23	20.53
Oct 23	20.75
Sep 23	22.1
Sep 23	21.02
Sep 23	21.76
Sep 23	21.97
Sep 23	22.68
Aug 23	22.22
Aug 23	21.29
Aug 23	21.7
Aug 23	23.48
Jul 23	39.03
Jul 23	31.01
Jul 23	28.48
Jul 23	26.3
Jun 23	27.4
Jun 23	30.7
Jun 23	30.94
Jun 23	29.72
Jun 23	28.67
May 23	27.38
May 23	25.71
May 23	26.37
May 23	26.47
Apr 23	36.97
Apr 23	41.12
Apr 23	39.7
Apr 23	36.78
Mar 23	37.01
Mar 23	39.98
Mar 23	39.98
Mar 23	42.63
Mar 23	43.95

Price/Operating Cashflow

KNSA Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 26	31.94
Sep 26	32.63
Aug 26	32.7
Aug 26	33.1
Aug 26	32.14
Aug 26	31.86
Jul 26	31.14
Jul 26	28.99
Jul 26	29.5
Jul 26	29.27
Jul 26	29.77
Jun 26	27.31
Jun 26	25.42
Jun 26	23.94
Jun 26	22.34
May 26	22.32
May 26	24.56
May 26	26.07
May 26	27.03
May 26	25.5
Apr 26	23.01
Apr 26	24.14
Apr 26	25.32
Apr 26	26.25
Mar 26	24.6
Mar 26	24.78
Mar 26	24.62
Mar 26	24.82
Feb 26	23.92
Feb 26	34.18
Feb 26	32.47
Feb 26	30.83
Jan 26	31.43
Jan 26	30.2
Jan 26	28.2
Jan 26	30.53
Jan 26	30.06
Dec 25	30.05
Dec 25	30.91
Dec 25	29.76
Dec 25	29.82
Nov 25	30.43
Nov 25	29.75
Nov 25	28.85
Nov 25	27.46
Oct 25	26.48
Oct 25	42.7
Oct 25	42.39
Oct 25	41.56
Oct 25	42.22
Sep 25	40.03
Sep 25	38.85
Sep 25	40.7
Sep 25	39.17
Aug 25	36.74
Aug 25	37.02
Aug 25	36.62
Aug 25	35.27
Aug 25	35.08
Jul 25	43.45
Jul 25	47.89
Jul 25	46.35
Jul 25	46
Jun 25	46.27
Jun 25	46.93
Jun 25	46.7
Jun 25	49.88
May 25	45.15
May 25	44.37
May 25	43.32
May 25	42.95
May 25	45.63
Apr 25	60.16
Apr 25	56.89
Apr 25	54.36
Apr 25	57.32
Mar 25	65
Mar 25	65.76
Mar 25	63.65
Mar 25	60.55
Feb 25	57.09
Feb 25	127.71
Feb 25	125.92
Feb 25	124.33
Jan 25	125.03
Jan 25	127.77
Jan 25	118.27
Jan 25	127.14
Jan 25	129.56
Dec 24	127.65
Dec 24	131.35
Dec 24	128.86
Dec 24	137.22
Nov 24	140.85
Nov 24	135.75
Nov 24	135.81
Nov 24	145.83
Nov 24	143.4
Oct 24	63.95
Oct 24	61.2

Price to Book

KNSA Price to Book by quarter
Period	Price to Book
Sep 26	9.05
Sep 26	9.24
Aug 26	9.26
Aug 26	9.37
Aug 26	9.1
Aug 26	9.02
Jul 26	8.82
Jul 26	7.94
Jul 26	8.08
Jul 26	8.01
Jul 26	8.15
Jun 26	7.48
Jun 26	6.96
Jun 26	6.56
Jun 26	6.12
May 26	6.11
May 26	6.73
May 26	7.14
May 26	7.4
May 26	6.98
Apr 26	5.59
Apr 26	5.87
Apr 26	6.15
Apr 26	6.38
Mar 26	5.98
Mar 26	6.02
Mar 26	5.98
Mar 26	6.03
Feb 26	5.82
Feb 26	6.57
Feb 26	6.24
Feb 26	5.92
Jan 26	6.04
Jan 26	5.8
Jan 26	5.42
Jan 26	5.87
Jan 26	5.78
Dec 25	5.77
Dec 25	5.94
Dec 25	5.72
Dec 25	5.73
Nov 25	5.85
Nov 25	5.72
Nov 25	5.54
Nov 25	5.28
Oct 25	5.09
Oct 25	5.78
Oct 25	5.73
Oct 25	5.62
Oct 25	5.71
Sep 25	5.41
Sep 25	5.25
Sep 25	5.5
Sep 25	5.3
Aug 25	4.97
Aug 25	5.01
Aug 25	4.95
Aug 25	4.77
Aug 25	4.74
Jul 25	4.18
Jul 25	4.61
Jul 25	4.46
Jul 25	4.43
Jun 25	4.45
Jun 25	4.52
Jun 25	4.49
Jun 25	4.8
May 25	4.34
May 25	4.27
May 25	4.17
May 25	4.13
May 25	4.39
Apr 25	3.52
Apr 25	3.33
Apr 25	3.19
Apr 25	3.36
Mar 25	3.81
Mar 25	3.85
Mar 25	3.73
Mar 25	3.55
Feb 25	3.35
Feb 25	3.29
Feb 25	3.24
Feb 25	3.2
Jan 25	3.22
Jan 25	3.29
Jan 25	3.04
Jan 25	3.27
Jan 25	3.33
Dec 24	3.28
Dec 24	3.38
Dec 24	3.32
Dec 24	3.53
Nov 24	3.62
Nov 24	3.49
Nov 24	3.49
Nov 24	3.75
Nov 24	3.69
Oct 24	4.48
Oct 24	4.29

No video analysis for this stock yet. Request one from our team.

News: KNSA

globenewswire.com · 4 Sep 2026

Kiniksa Pharmaceuticals to Present at Wells Fargo 21st Annual Healthcare Conference

LONDON, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026 at 8:45 a.m. Eastern Time.

marketbeat.com · 14 Aug 2026

Kiniksa Highlights ARCALYST Growth as KPL-387 Advances Into Phase 3

Kiniksa Pharmaceuticals International NASDAQ: KNSA said its commercialized recurrent pericarditis treatment ARCALYST continues to grow, while the company has begun a pivotal Phase 3 study of follow-on candidate KPL-387.

globenewswire.com · 7 Aug 2026

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

LONDON, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026 at 9:00 a.m. Eastern Time.

zacks.com · 3 Aug 2026

KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook

KNSA lifted 2026 ARCALYST sales guidance as Q2 revenue surged, while advancing KPL-387 into Phase 3 to support its next growth driver.

zacks.com · 30 Jul 2026

Earnings Estimates Rising for Kiniksa Pharmaceuticals International, plc (KNSA): Will It Gain?

Kiniksa Pharmaceuticals International, plc (KNSA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

seekingalpha.com · 28 Jul 2026